Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect

Solymosi, T; Otvos, Z; Angi, R; Ordasi, B; Jordan, T; Molnar, L; McDermott, J; Zann, V; Church, A; Mair, S; Filipcsei, G; Heltovics, G; Glavinas, H

Glavinas, H (reprint author), NanGenex Inc, 47-49 Madarasz Viktor U, H-1138 Budapest, Hungary.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017; 80 (4): 723

Abstract

Zytiga (abiraterone acetate, AA) is known to exhibit very low bioavailability and a significant positive food effect in men. The unfavorable pharmacok......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索